BioVie Inc. (BIVI) vs RVL Pharmaceuticals PLC (RVLP)

BioVie Inc. and RVL Pharmaceuticals PLC are both Biotechnology companies. BioVie Inc. and RVL Pharmaceuticals PLC are of similar size ($14.1M and $13.8M). BioVie Inc. has the higher net margin (0.00% vs −184.9%) and the lower return on invested capital (−1,095.0% vs −80.5%). Across the 13 metrics below, BioVie Inc. leads on 7 and RVL Pharmaceuticals PLC on 6.

Valuation

Metric BIVI RVLP Biotechnology median
P/E n/m n/m 7.88
P/S n/m n/m 11.47
P/B 1.14 n/m 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales n/m 1.05 10.73
Earnings yield (195.65%) 0.00% (28.84%)
Free cash flow yield (163.08%) 0.00% (23.03%)

Profitability

Metric BIVI RVLP Biotechnology median
Gross margin 0.00% 74.73% 65.16%
Operating margin 0.00% (191.72%) 0.00%
Net margin 0.00% (184.91%) 0.00%
Free cash flow margin 0.00% (128.42%) 0.00%
Return on equity (151.06%) (182.44%) (57.72%)
Return on assets (123.51%) (64.94%) (49.22%)
Return on invested capital (1,095.01%) (80.54%) 0.00%

Growth

Metric BIVI RVLP Biotechnology median
Revenue growth (TTM) — 5.64% 5.64%
EPS growth (last fiscal year) 74.83% 39.58% —
Revenue growth, 5-year CAGR — (27.35%) 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BIVI RVLP Biotechnology median
Debt to equity 0.00 3.54 0.00
Current ratio 3.59 0.38 4.73
Net debt to EBITDA 0.40 (0.29) 0.96

Dividend

Metric BIVI RVLP Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric BIVI RVLP Biotechnology median
Market cap 13.82m 14.08m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack